187 related articles for article (PubMed ID: 12629454)
1. A new dark side of the Maillard's products.
Wautier JL
Diabetes Metab; 2003 Feb; 29(1):86-7. PubMed ID: 12629454
[No Abstract] [Full Text] [Related]
2. Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNF-alpha signaling.
Csiszar A; Ungvari Z
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H475-6. PubMed ID: 18599592
[No Abstract] [Full Text] [Related]
3. Diabetic macrovascular disease: the glucose paradox?
Libby P; Plutzky J
Circulation; 2002 Nov; 106(22):2760-3. PubMed ID: 12450998
[No Abstract] [Full Text] [Related]
4. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.
Bierhaus A; Ritz E; Nawroth PP
Nephrol Dial Transplant; 1996; 11 Suppl 5():87-90. PubMed ID: 9044315
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in advanced glycation end products and diabetic complications.
Vlassara H
Diabetes; 1997 Sep; 46 Suppl 2():S19-25. PubMed ID: 9285494
[No Abstract] [Full Text] [Related]
6. Blood vessel wall interactions in diabetes.
Schrör K
Diabetes; 1997 Sep; 46 Suppl 2():S115-8. PubMed ID: 9285512
[No Abstract] [Full Text] [Related]
7. Molecular biology of the peritoneal membrane: in between morphology and function.
Anglani F; Forino M; Del Prete D; Ceol M; Favaro S
Contrib Nephrol; 2001; (131):61-73. PubMed ID: 11125564
[No Abstract] [Full Text] [Related]
8. [AGE receptor].
Matsumoto K; Sano H; Horiuchi S
Nihon Rinsho; 1997 Nov; 55 Suppl():867-71. PubMed ID: 9434579
[No Abstract] [Full Text] [Related]
9. Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy.
Chiarelli F; Mansour M; Verrotti A
Diabetes Nutr Metab; 2000 Aug; 13(4):192-9. PubMed ID: 10961486
[No Abstract] [Full Text] [Related]
10. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors.
Vlassara H; Bucala R
Diabetes; 1996 Jul; 45 Suppl 3():S65-6. PubMed ID: 8674896
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
12. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose.
Yan SD; Stern D; Schmidt AM
Eur J Clin Invest; 1997 Mar; 27(3):179-81. PubMed ID: 9088851
[No Abstract] [Full Text] [Related]
13. RAGE: a novel target for drug intervention in diabetic vascular disease.
Hudson BI; Schmidt AM
Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
[TBL] [Abstract][Full Text] [Related]
14. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
15. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products and vascular structure and function.
Soldatos G; Cooper ME
Curr Hypertens Rep; 2006 Dec; 8(6):472-8. PubMed ID: 17087858
[TBL] [Abstract][Full Text] [Related]
17. RAGE in diabetic nephropathy.
Yamamoto H; Watanabe T; Yamamoto Y; Yonekura H; Munesue S; Harashima A; Ooe K; Hossain S; Saito H; Murakami N
Curr Mol Med; 2007 Dec; 7(8):752-7. PubMed ID: 18331233
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of diabetic angiopathy--clues for innovative therapeutic interventions.
Bierhaus A; Ziegler R; Nawroth PP
Horm Res; 1998; 50 Suppl 1():1-5. PubMed ID: 9676989
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation endproducts and their receptor: do they play a role in diabetic cardiomyopathy?
Arai M
J Mol Cell Cardiol; 2002 Oct; 34(10):1305-8. PubMed ID: 12392990
[No Abstract] [Full Text] [Related]
20. AGE in micro- and macroangiopathy.
Lapolla A; Traldi P; Fedele D
Contrib Nephrol; 2001; (131):10-21. PubMed ID: 11125555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
